| Market Size in 2023 | Market Forecast in 2032 | Growth Rate (in %) | Base Year |
|---|---|---|---|
| USD 10.19 Billion | USD 16.93 Billion | CAGR at 5.80% | 2023 |
According to the report published by Zion Market Research, the global Medical Footwear Market size was valued at USD 10.19 Billion in 2023 and is predicted to reach USD 16.93 Billion by the end of 2032. The market is expected to grow with a CAGR of 5.80% during the forecast period. The report analyzes the global Medical Footwear Market’s growth drivers, restraints, and impact on demand during the forecast period. It will also help navigate and explore the arising opportunities in the Medical Footwear Market industry.
Medical footwear is the shoes that are specifically designed to accommodate or support the mechanics and structure of the leg, ankle, and foot. Medical footwear has numerous medically beneficial functions and features that make them distinct from everyday footwear. Most of this footwear also features a removable insole that can be replaced by custom Orthotic or can be used for cushioning and is an important feature of medical footwear.
The global medical footwear market is growing at a significant rate. The growing prevalence of diabetes, the growing number of foot-related issues, and the increase in healthcare expenditure are some of the factors that are majorly contributing to the growth of the global market. As per the report of CDC’s National Diabetes Statistics Report for 2020, in the United States alone, the overall cases of diabetes have increased to around 34.2 million. Nearly, 7.3 million people are living with diabetes but are not yet diagnosed (2018). Almost half of the people living with diabetes have diabetic neuropathy that is nerve damage. It can occur in any part of the body, but nerves in the legs and foot are affected mostly.
Also, nerve damage with poor blood flow is another complication among diabetic patients which may increase the risk of developing a foot ulcer. Thus, people with diabetes need to be more cautious about foot-related issues. To make life easier, the manufacturers have made available an outstanding collection of orthopedic and diabetic footwear for both men and women. It also includes numerous styles such as diabetic shoes, slippers, sandals, and much more which enables the diabetics to live energetic and full lives with an active lifestyle while protecting their feet. All these key aspects are remarkably driving the growth of the global medical footwear market.
Moreover, the presence of strong distribution channels, rise in e-commerce platforms, and rise in demand for medical footwear from the healthcare environment are some of the additional key factors that are fueling the growth of the global market. Furthermore, the rise in health-related concerns and the growing adoption of medical footwear owing to its benefits over regular footwear are likely to offer huge opportunities for the growth of the global medical footwear market during the forecast period. However, the high cost associated with medical footwear may hinder the growth of the global medical footwear market.
The global medical footwear market is severely hit by COVID-19 pandemic situations. The market is mainly influenced by strict rules of lockdowns imposed by several governments around the world. Strict lockdowns resulted in disruption of the supply chain, manufacturing processes, and product distribution. Due to all these factors, the overall sale of the product reduced significantly. However, the market is expected to return on track and register healthy growth over the forecast period.
The global medical footwear market is classified based on price range, footwear type, application, distribution channel, end-user, and region.
Based on the price range, the global medical footwear market is split into less than 50 USD, 50 USD-100 USD, and more than 100 USD.
Based on the footwear type, the global market is segregated into sandals, shoes & boots, and others.
Based on the application, the market is divided into flat feet shoes, bunions & hallux valgus shoes, arthritis shoes, diabetic shoes, and others.
The distribution channel segment is bifurcated into offline and online.
Based on end-user, the market is categorized into kids, women, and men.
| Report Attributes | Report Details |
|---|---|
| Report Name | Medical Footwear Market Research Report |
| Market Size in 2023 | USD 10.19 Billion |
| Market Forecast in 2032 | USD 16.93 Billion |
| Growth Rate | CAGR of 5.80% |
| Number of Pages | 196 |
| Key Companies Covered | DARCO International, Inc., Dr. Zen, Inc., Dr. Foot Inc., Drew Shoe, DJO, LLC (Dr. Comfort), Podartis srl, Aetrex Worldwide, Inc., OrthoFeet, Horng Shin Footwear Co., and Gravity Defyer Corp, among others. |
| Segments Covered | By Price range, By Footwear type, By Application, By Distribution channel, By End-user and By Region |
| Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
| Base Year | 2023 |
| Historical Year | 2018 to 2022 |
| Forecast Year | 2024 - 2032 |
| Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
Asia Pacific is expected to hold a major share in the global medical footwear market. Also, the market is expected to set a healthy growth over the forecast period. Key factors that are anticipated to propel the growth of the market in this region include a large number of customers, a growing number of chronic diseases, and the presence of key players along with local manufactures. Besides, growing disposable income in developing countries in the region such as India and China is also contributing to the growth of the market. North America is expected to be the second-largest market for medical footwear followed by Europe.
Some of the prominent players operating in the global medical footwear market are:
By Price range
By Footwear type
By Application
By Distribution channel
By End-user
By Region
What Reports Provides
FrequentlyAsked Questions
Medical footwear is designed to support foot health and reduce pain. It is commonly used for diabetes, orthopedic, and post-surgery care.
The global Medical Footwear market is expected to be driven by the Growth is supported by rising prevalence of diabetes and orthopedic conditions, aging population, and increasing awareness of foot health. Demand for comfort-focused and therapeutic footwear boosts adoption.
According to study, the global Medical Footwear market size was worth around USD 10.19 Billion in 2023 and is predicted to grow to around USD 16.93 Billion By 2032.
The global Medical Footwear market is expected to grow at a Compound Annual Growth Rate (CAGR) of around CAGR 5.80% during the forecast period from 2024-2032.
The global Medical Footwear industry is projected to be challenged by Challenges include limited reimbursement in some regions, product fit and comfort variability, competition from low-cost alternatives, and need for clinical validation for therapeutic claims.
The Opportunities include aging population growth, rising diabetes and orthopedic conditions, expanding custom/3D-printed orthotics, and increasing availability through e-commerce and specialty clinics will offer significant growth opportunities in the Medical Footwear market.
3D scanning and custom orthotics at scale; lightweight, antimicrobial and breathable materials; smart insoles for gait/pressure monitoring are the emerging trends and innovations impacting the Medical Footwear market.
The global Medical Footwear market is expected to be led by Europe during the forecast period.
Some of the prominent players operating in the global Medical Footwear market are; DARCO International, Inc., Dr. Zen, Inc., Dr. Foot Inc., Drew Shoe, DJO, LLC (Dr. Comfort), Podartis srl, Aetrex Worldwide, Inc., OrthoFeet, Horng Shin Footwear Co., and Gravity Defyer Corp, among others. and others.
The report explores crucial aspects of the Medical Footwear market, including a detailed discussion of existing growth factors and restraints, while also browsing future growth opportunities and challenges that impact the market.
HappyClients